PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

FDA clears bionic pancreas developed in BU Lab for people with type 1 diabetes

The iLet Bionic Pancreas, which automates insulin delivery to manage the chronic disease, was invented in Ed Damiano’s biomedical engineering lab—and inspired by his son

FDA clears bionic pancreas developed in BU Lab for people with type 1 diabetes
2023-05-23
(Press-News.org) A bionic pancreas—a wearable, pocket-sized, automated insulin delivery device—that was first developed in a Boston University lab has been cleared by the US Food and Drug Administration (FDA). The iLet Bionic Pancreas is now commercially available, bringing fresh hope to the almost two million Americans with type 1 diabetes.

The approval is a massive milestone in a two-decade—and deeply personal—journey. Invented 20 years ago in the lab of Ed Damiano, a BU College of Engineering professor of biomedical engineering, the bionic pancreas combines an insulin infusion pump with algorithm-controlled dosing decision software. Damiano was inspired to develop the system by his son, who was diagnosed with type 1 diabetes when he was just 11 months old.

When paired with a Bluetooth-enabled glucose monitor, the iLet can deliver tailored insulin doses every five minutes, based on calculations of current and past glucose levels and the body’s reaction to past insulin deliveries. Small enough to be clipped on a bra strap or thrown in a pocket, the iLet means patients will no longer have to constantly measure their glucose levels and calculate, with help from their doctor, their correct insulin dose—a 24/7 endeavor. The iLet was cleared for people aged six years and older with type 1 diabetes.

“Today’s action will provide the type 1 diabetes community with additional options and flexibilities for diabetes management and may help to broaden the reach of AID [automated insulin dosing] technology,” said Jeff Shuren, director of the FDA’s Center for Devices and Radiological Health, in a statement announcing the decision. “The FDA is committed to advancing new device innovation that can improve the health and quality of life for people living with chronic diseases that require day-to-day maintenance, like diabetes, through precision medicine approaches.”

For most of his son’s early life, Damiano and his partner would wake every few hours in the night, checking their son’s blood sugar levels, giving him insulin or juice to control the numbers. In people with type 1 diabetes, the pancreas doesn’t produce enough insulin—an essential hormone for converting and storing sugars. The chronic condition carries a host of complications, from heart disease to eye damage. There’s no cure.

Back in 2013, nearly a decade into the bionic pancreas’ development, Damiano talked with Bostonia about the fear and panic of those nighttime checks—which often started with making sure his son was still warm, still breathing.

“Sleeping is the scariest part of all this,” he told Bostonia. “It’s what put this project on a high-speed rail. It’s a very scary prospect that blood sugars could go low at night. When you’re sleeping, you’re checked out—you don’t want to check out permanently.”

In 2015, Damiano cofounded Beta Bionics, a public benefit corporation, to advance the technology; four years later, the company raised $126 million to push the device through the final stages of its development. Given the iLet’s origins—and Damiano’s very personal motivation for ensuring its success—the FDA’s approval came on a fitting date.

“This milestone is particularly poignant to me as the news of FDA clearance coincided with the 24th birthday of my son, David, who developed type 1 diabetes as an infant, just over 23 years ago,” says Damiano, founder and executive chairman at Beta Bionics.

David graduated summa cum laude from BU in 2021, double majoring in history and international relations. He’s now a researcher at a documentary and feature film production company.

“The bionic pancreas project has its origins with David, but the experimental research got started in my lab at Boston University almost 20 years ago,” says Damiano. “My appreciation and affection for Boston University runs deep. I will always be grateful to the multitudes of people from across the institution who came together to support my research team’s efforts over the years.”

Damiano’s coinventor was Firas El-Khatib, formerly a senior research scientist at BU and now Beta Bionics’ vice president of research and innovation. In fall 2023, they were coauthors on a study that found the iLet helped adults and children maintain healthier blood glucose levels, outperforming existing standard-of-care methods—a significant step on its path to FDA clearance.

According to Beta Bionics, users of the iLet just need to enter their weight to get started—the system will then use continuous learning to do the rest, regulating blood glucose levels with minimal input.

One of those who has followed the iLet’s progress from idea to product is Kenneth R. Lutchen, ENG dean and a professor of biomedical engineering. He was chair of biomedical engineering when Damiano began laying the groundwork for the bionic pancreas and helped the team acquire initial funding, securing internal translational resources and a grant from the Wallace H. Coulter Foundation.

“I am so proud of Boston University and Ed Damiano working together to spawn what has now become a product that will transform the quality of life for so many human beings suffering from type 1 diabetes, and in a way never before imaginable,” says Lutchen. “I watched Ed Damiano’s inexhaustible energy and brilliance sustain development of the iLet from concept to the early studies on animals to the clinical trials and now to a product.

“This is such a fantastic example of what a Boston University societal engineer does—advancing new ideas into real inventions driven for the betterment of others.”

END

[Attachments] See images for this press release:
FDA clears bionic pancreas developed in BU Lab for people with type 1 diabetes

ELSE PRESS RELEASES FROM THIS DATE:

A troubling reaction to school violence compounds the crisis

2023-05-23
Ann Arbor, May 23, 2023 – High school students who experience violence or bullying at school are more likely to bring weapons like a gun, knife, or club to school than those who have not experienced violence, according to a new study in the American Journal of Preventive Medicine, published by Elsevier. Because weapons increase the potential for injury and death when there is interpersonal conflict, developing a better understanding of the relationship between exposure to violence and weapon carrying is essential for developing effective public health interventions. “With 93 school shootings in the US just the 2020-21 period alone, ...

José Andrés and the George Washington University’s groundbreaking new institute to lead the world in delivering food system solutions

2023-05-23
WASHINGTON, D.C. (May 23, 2023) – World-renowned chef, author, and humanitarian José Andrés and international research leader the George Washington University (GW) today announced their partnership to build a premier Global Food Institute at GW, an unprecedented and transformative collaboration in the heart of the nation’s capital with plans to be a world leader in food system solution delivery. “Our global food system is experiencing a crisis, brought on by systemic inequities, rampant hunger and poverty, the climate crisis, and deteriorating public health and nutrition. But food has the power to solve problems: It can rebuild lives and communities, heal ...

COPDGene study follows emphysema patients over 10 years

2023-05-23
Researchers at National Jewish Health evaluating computerized tomography (CT) scans of emphysema progression in the COPDGene® study showed that, during a span of 10 years, participants with pre-existing emphysema who continued smoking had the largest decline in adjusted lung density (ALD). The lung density decline was notably worse in current smokers compared with former smokers. The study is significant because reliably measuring changes in emphysema over time has always been challenging, due in part to differences in CT equipment technology and imaging parameters across institutions. The study, which published ...

Trial aims to improve treatment for newborns with life-threatening sepsis

Trial aims to improve treatment for newborns with life-threatening sepsis
2023-05-23
An international clinical trial co-led by UCL (University College London) researchers will evaluate much-needed new antibiotic combinations for newborn babies with sepsis. The trial, which has started in three public hospitals in South Africa and Kenya, will be expanded to other countries and regions in 2024, with a target of recruiting up to 3,000 newborns overall. The NeoSep1 trial will evaluate new combinations of generic antibiotics and compare them to existing treatment regimens that are often used in newborn babies with suspected neonatal sepsis. Chris Hani Baragwanath Academic Hospital in Johannesburg, Tygerberg ...

Previous smallpox vaccine provides immunity to mpox

2023-05-23
Vaccines against smallpox given until the mid-1970s offer continuing cross-reactive immunity to mpox (previously known as monkeypox), researchers from Karolinska Institutet in Sweden report in a study published in the scientific journal Cell Host & Microbe. During last year’s mpox outbreak, the virus spread for the first time outside Africa, causing over 85,000 cases of the disease to date. Men who have sex with men account for the most infections, with a marked skew towards the young. The virus that causes mpox is what is known as an orthopoxvirus and is very similar to the virus that caused ...

Fever found to be most common non-respiratory feature of SARS-CoV-2 infection

Fever found to be most common non-respiratory feature of SARS-CoV-2 infection
2023-05-23
Session:  C58, Health Services Research in Diverse Settings Date and Time: 11:30 a.m. ET, Tuesday, May 23, 2023 Location:  WEWCC, Area 1, Hall C (Lower Level)   ATS 2023, Washington, DC – Fever was found to be the most common non-respiratory feature of infection with SARS-CoV-2, the virus that causes COVID-19, according to research published at the ATS 2023 International Conference.  The finding held true regardless of which COVID variant patients had, and whether or not they were fully vaccinated or not fully vaccinated. The researchers, who also looked at mortality risk, found that patients who were ...

International group of experts redefines concussions

2023-05-23
Doctors and other health-care providers have a new standard for diagnosing mild traumatic brain injury (TBI), thanks to a thorough process led by researchers from the University of B.C. and Harvard-affiliated Spaulding Rehabilitation Hospital. "We've achieved consensus across a diverse range of experts in developing these new diagnostic criteria,” said Dr. Noah Silverberg, associate professor in UBC’s department of psychology, member of the Djavad Mowafaghian Centre for Brain Health and Centre for Aging SMART at Vancouver Coastal Health, and co-lead of the project. “Our ...

USC Health System Board appoints Paul B. Rothman, MD, as board member

USC Health System Board appoints Paul B. Rothman, MD, as board member
2023-05-23
LOS ANGELES — Paul B. Rothman, MD, has been appointed as a member of the USC Health System Board, which provides strategic oversight and governance over Keck Medicine of USC and university clinical services.  Rothman, former CEO of Johns Hopkins Medicine and retired dean of medical faculty for the Johns Hopkins University School of Medicine, brings his leadership acumen as well as clinical and scientific expertise in rheumatology and molecular immunology to this advisory role.  “Paul ...

Diagnosis of type 1 diabetes after SARS-CoV-2 infection: Researchers find possible correlation

2023-05-23
Different studies have documented an increased incidence of type 1 diabetes during the COVID-19 pandemic. However, none of the studies distinguishes between children with and without SARS-CoV-2 infection. Researchers were now able to gain new insights: the KVB data set provides information on whether children diagnosed with type 1 diabetes previously had COVID-19. This allows an analysis of the temporal relationship between a COVID-19 diagnosis and the diagnosis of type 1 diabetes. Amongst the analyzed children without ...

RPI and Albany Medical College researchers awarded $3.3 million to improve breast cancer treatment using artificial intelligence

RPI and Albany Medical College researchers awarded $3.3 million to improve breast cancer treatment using artificial intelligence
2023-05-23
Researchers from Rensselaer Polytechnic Institute (RPI) and Albany Medical College were awarded a $3.3 million grant over five years by the National Cancer Institute to use artificial intelligence (AI) to improve targeted drug therapy in HER2-positive breast cancer treatment. HER2-positive breast cancer tends to grow and spread quickly, but targeted treatments improve outcomes. The research is being led by Xavier Intes, Rensselaer professor of biomedical engineering and co-director of the Center for Modeling, Simulation and Imaging in Medicine, and ...

LAST 30 PRESS RELEASES:

Generative AI tools like Pix2Pix–BicycleGAN are revolutionizing landscape design by enhancing masterplan generation and rendering

Expanding APAC presence, Insilico Medicine seals strategic collaboration on AI-driven mash therapy development with Korean Biotech Therasid Bioscience

When it comes to butterflies, people prefer pretty ones. That’s a problem for scientists.

UBC Okanagan study raises concerns about partner violence in queer relationships

Human-infecting parasite produces sterile soldiers like ants and termites

The unintended consequences of success against malaria

Taco-shaped arthropod from Royal Ontario Museum’s Burgess Shale fossils gives new insights into the history of the first mandibulates

Butterflies accumulate enough static electricity to attract pollen without contact, new research finds

Eyes for Love: Searching for light and a mate in the deep, dark sea, male dragonfishes grow larger eyes than the females they seek

PNNL scientists tap nation’s fastest computers to explore critical science questions

Peri-operative care of transgender and gender-diverse individuals: new guidance for clinicians and departments published

Clinical psychologist’s book addresses largely ignored problem: social anxiety

Researchers leveraging AI to train (robotic) dogs to respond to their masters

Drawing water from dry air

Combining trapped atoms and photonics for new quantum devices

A new way to make element 116 opens the door to heavier atoms

New genetic tool could identify drug targets for diseases associated with metabolic dysfunction

Plant Biologist Siobhan Brady named HHMI Investigator

Long-acting injectable cabotegravir for HIV prevention is safe in pregnancy

Large language models don’t behave like people, even though we may expect them to

NREL researchers highlight opportunities for manufacturing perovskite solar panels with a long-term vision

Top Medicare advantage plans less available in disadvantaged areas

Better carbon storage better carbon storage with stacked geology with stacked geology

Sharp temperature reduction for quantum dots in polymer by highly efficient heat dissipation pathways

UAF researcher creates way to detect elusive volcanic vibrations

Lissajous pattern multi-pass cell: Enhancing high sensitivity and simultaneous dual-gas LITES sensing

Asexual reproduction usually leads to a lack of genetic diversity. Not for these ants.

Mini lungs make major COVID-19 discoveries possible

Exploratory analysis associates HIV drug abacavir with elevated cardiovascular disease risk in large global trial

Control of light–matter interactions in two-dimensional materials with nanoparticle-on-mirror structures

[Press-News.org] FDA clears bionic pancreas developed in BU Lab for people with type 1 diabetes
The iLet Bionic Pancreas, which automates insulin delivery to manage the chronic disease, was invented in Ed Damiano’s biomedical engineering lab—and inspired by his son